Expansion momentum Koning Health has recently expanded US offices and Vera Scan installations, signaling growing market adoption and readiness for scaled deployments, which presents opportunities to target hospitals, imaging centers, and ambulatory networks expanding breast imaging capabilities.

Strategic partnerships Recent collaborations, such as Bedford Breast Center partnership, indicate a channel through early adopters and reference sites that can be leveraged to accelerate sales through case studies, clinician endorsements, and regional expansion.

Regulatory readiness With FDA, CE-Mark, CFDA, TGA, and Health Canada approvals, Koning Health demonstrates global regulatory readiness, enabling traction with multi-region procurement teams and hospitals seeking compliant, cutting-edge breast imaging solutions.

Clinical leadership Appointment of Co-Chief Medical Officers strengthens clinical credibility and clinician-facing engagement, creating opportunities to position Vera Breast CT for physician-led pilot programs, outcomes studies, and reimbursement discussions.

Competitive differentiation Advanced 3D imaging via cone-beam CT and strong IP portfolio position Koning Health as a potential substitute for traditional mammography, prompting upsell to centers seeking higher diagnostic accuracy and patient comfort with lower long-term costs.